Clinical Pharmacogenetics Implementation Consortium

Carbamazepine is an anticonvulsant or anti-epileptic drug that has a structure similar to that of tricyclic antidepressants. It has been approved by the US Food and Drug Administration as treatment for epilepsy, other seizure disorders, bipolar disorder and trigeminal neuralgia.